Skip to content

Total debt at other companies

HRO
HarrowHROW
$308.58M-32.9%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$1.15M-98.1%
XER
Xeris Biopharma Holdings, Inc.XERS
$258.55M-3.8%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$305.29M-3.5%
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
$47.86M-5.8%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$2.68M-13.3%

Other financials

Income statement

See full
Revenue$24.3M+40.4%
Gross profit$14.7M+49.4%
Operating income$2.4M+614%
Net income$1.6M+199%
EPS (diluted)$0.05+183%

Balance sheet

See full
Cash & equivalents$19.7M+12.9%
Total equity$30.6M+25.2%
Total assets$97.7M+16.3%

Cash flow

See full
Operating cash flow$7.4M+254%
CapEx$75.0K
Free cash flow$7.3M+251%

Valuation

See full
Market cap$930.79M+156%
Enterprise value$942.39M+150%
P/S10.7×+3.2×

Profitability

See full
Gross margin54.8%-3.7pp
Operating margin-15.1%
Net margin-9.5%-2.7pp
FCF margin17.1%

Returns & leverage

See full
Return on equity-34.2%+0.9pp
Debt / equity-0.2×
Current ratio1.2×-0.8×

Where this comes from

Calculated from Eton Pharmaceuticals, Inc.’s reported figures.

The official record: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eton Pharmaceuticals, Inc.'s total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Eton Pharmaceuticals, Inc.'s total debt?
Eton Pharmaceuticals, Inc. (ETON) reported total debt of $31.26M in Q1 2026.
How has Eton Pharmaceuticals, Inc.'s total debt changed year-over-year?
Eton Pharmaceuticals, Inc.'s total debt increased by 3.7% year-over-year, from $30.16M to $31.26M.
What is the long-term trend for Eton Pharmaceuticals, Inc.'s total debt?
Over 5 years (2020 to 2025), Eton Pharmaceuticals, Inc.'s total debt has grown at a 32.6% compound annual growth rate (CAGR), from $7.58M to $31.08M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.